Notícias

Nvidia earnings are Wednesday but rival Advanced Micro Devices is the chip maker that could capitalize on booming CPU demand.

BBIO's Q2 sales jump 120% as Attruby drives growth, while higher spending widens the loss and raises the stakes for 2026.

BridgeBio's fast-growing Attruby sales and pipeline expansion face a steep valuation premium, continued losses and launch risks.

Stocks Push Higher Before Nvidia Earnings as Inflation Data Adds to the Stakes

Three catalysts, one reshuffling, and a Fed that refuses to move

BridgeBio's 24% three-month rally faces a higher bar as Attruby growth and pipeline catalysts compete with valuation and execution risks.

Comstock's improving production and deep inventory offer upside, but heavy spending, leverage and weaker estimates keep the near-term case in check.

RUM Group CEO Chris Pavlovski just publicly named CoreWeave and Nebius as targets for his company's AI infrastructure arm, but the SEC filing sitting behind that bold claim reveals a financing gap that could stop the Maysville data center before it starts.

Moderna Stock Jumps as Wolfe Upgrade Puts Cancer Pipeline in Spotlight

FedEx is IBD Stock Of The Day after streamlining its parcel delivery and logistics businesses. Intraday, FDX stock eased near a buy point. In 2026, the Memphis-based company has shifted away from consumer parcel delivery to target higher-margin, business-to-business segments.

These two data storage device specialists are similar companies, but there are a few key differences.

Gold may have gotten ahead of itself for now. It's pausing after rallying into a key technical level, getting stretched to the upside in the process.

Bitcoin is barely budging, yet certain mining and treasury stocks are surging several times faster than the coin itself. The reason comes down to a leverage mechanic baked into how these companies make money.

Shares of Apnimed rose 8% Tuesday after BofA Securities initiated coverage of the company with a Buy rating and a $41 price target. The rating is based on a risk-adjusted discounted cash flow analysis of Oxnimbi (AD109), Apnimed's sole asset and an oral therapy for obstructive sleep apnea...

Retail brokers are catching a strong bid at midday Tuesday even as the underlying crypto tape barely budges. Robinhood Markets (NASDAQ:HOOD) stock is up 7% to $110.97, while Webull (NASDAQ:BULL) stock is climbing 4% to $8.86. The trigger sits with Webull CEO Anthony Denier, who told CNBC that retail buy orders for the largest cryptocurrencies ... Robinhood Rises 7%, Webull Climbs 4% as a Day Trading Rule Repeal Ignites Retail Crypto Orders

Mattel's Q2 sales rose 10% and beat estimates, but weaker margins and higher expenses drove a sharp earnings decline despite reaffirmed 2026 guidance.

Mattel's discounted valuation and broader growth engines offer upside potential, but margin pressure and category weakness keep the outlook mixed.

You have no idea when or where the next record high is going to be made. You only know that it eventually will be.

The rally in both assets followed $5.74 million of net inflows into U.S. spot HYPE ETFs on Monday, the second-highest daily inflow on record.

Johnson and Johnson has surged over 54% in a year, cleared a major FDA hurdle, and raised its guidance, yet something about the current setup gives pause before hitting buy.

Morgan Stanley (MS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.

The discount retailer is up 74% this year. That is not a typo. The gains can keep coming.

Energy Transfer's 5.9% monthly rally is backed by fee-based cash flows, data-center demand and expansions, but high debt and lower ROE warrant caution.

Taiwan Semiconductor is riding on surging AI demand, advanced-node adoption and global capacity expansion as revenues and earnings maintain strong growth momentum.

One company just turned profitable on a 17.5% net margin; the other commands 97% of Fortune 500 but carries $31.5B in debt.

MNST trades above its 50- and 200-day SMAs as energy-drink growth, innovation and global momentum offset rising cost pressures.

Kraft Heinz beat Q2 earnings and sales estimates and raised its 2026 organic sales outlook, but weak North America volumes and margin pressure remain.

Kraft Heinz trades at a discount and generates strong cash flow, but weak volumes, inflation and softer earnings keep execution risk in focus.

Has the market finally become too pessimistic about Netflix, or has the sell-off created a place to jump in?